Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bevacizumab: overview of the literature.
Braghiroli MI, Sabbaga J, Hoff PM. Braghiroli MI, et al. Among authors: sabbaga j. Expert Rev Anticancer Ther. 2012 May;12(5):567-80. doi: 10.1586/era.12.13. Expert Rev Anticancer Ther. 2012. PMID: 22594892 Review.
A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma.
Smaletz O, Diz MD, do Carmo CC, Sabbaga J, Cunha-Junior GF, Azevedo SJ, Maluf FC, Barrios CH, Costa RL, Fontana AG, Madrigal V, Wainstein AJ, Yeda FP, Alves VA, Moro AM, Blasbalg R, Scott AM, Hoffman EW. Smaletz O, et al. Among authors: sabbaga j. Gynecol Oncol. 2015 Aug;138(2):272-7. doi: 10.1016/j.ygyno.2015.05.023. Epub 2015 May 27. Gynecol Oncol. 2015. PMID: 26026738 Clinical Trial.
Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer.
Miranda VC, Braghiroli MI, Faria LD, Bariani G, Alex A, Bezerra Neto JE, Capareli FC, Sabbaga J, Lobo Dos Santos JF, Hoff PM, Riechelmann RP. Miranda VC, et al. Among authors: sabbaga j. Clin Colorectal Cancer. 2016 Dec;15(4):321-328.e1. doi: 10.1016/j.clcc.2016.04.011. Epub 2016 May 7. Clin Colorectal Cancer. 2016. PMID: 27262895 Clinical Trial.
51 results